Drug Resistance Mechanisms on Colorectal Cancer

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Journal of Basic and Clinical Health Sciences
Volume:5 Issue:1
Drug Resistance Mechanisms on Colorectal Cancer

Drug Resistance Mechanisms on Colorectal Cancer

Authors : Hasan KURTER, Janberk YEŞİL, Ezgi DASKIN, Gizem ÇALIBAŞI KOÇAL, Hülya ELLİDOKUZ, Yasemin BAŞBINAR

Pages : 88-93

Doi:10.30621/jbachs.869310

View : 49 | Download : 33

Publication Date : 2021-02-26

Article Type : Review Paper

Abstract :Standard treatment for colorectal cancer includes surgery, radiotherapy, and chemotherapy. Conventional chemotherapeutic agents used in colorectal cancer such as 5-fluorouracil, capecitabine which is oral form of 5-fluorouracil, irinotecan, and oxaliplatin. One of the major challenges in chemotherapy considered as drug resistance. Drug resistance occurs in many different mechanisms such as alteration in tumor microenvironment, growth kinetics, genetic variations, and tumor heterogeneity. These cytotoxic agents are used in combination form to overcome drug resistance on colorectal cancer. They can also be used in combination with cytotoxic agents as bevacizumab and cetuximab. Combination therapy depends on tumor burden, type, stage, and molecular characteristics. It is crucial to choose the combination therapy to be applied by taking these factors into consideration. In this review, current drug resistance mechanisms were discussed and then mechanisms of conventional chemotherapy related resistance were explained.
Keywords : Drug resistance, colorectal cancer, chemotherapy, drug combinations

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.